Determinants of acquisition and clearance of human papillomavirus infection in previously unexposed young women

Autor: El-Zein, Mariamt, Ramanakumar, Agnihotram V., Naud, Paulo Sergio Viero, Martins, Cecilia M. Rotelli, Carvalho, Newton S. de, Borba, Paola Colares de, Teixeira, Júlio César, Moscicki, A. B., Harper, Diane M., Tyring, Stephen K., Ramjattan, Brian, Dubin, Gary, Franco, Eduardo Luis Fabiano, HPV-007 Study Group

Publikováno v: Repositório Institucional da UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS

Background Global variation in human papillomavirus (HPV) prevalence and persistence may be explained by differences in risk factors, such as sexual activity, oral contraceptive use, and behavioral factors. We evaluated determinants of acquisition an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3056::812c22f1e0f85098c9b1b1486a44680c

Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial.

Autor: Ramanakumar AV; Division of Cancer Epidemiology, McGill University, Montreal, Quebec, Canada., Naud P; Federal University of Rio Grande do Sul-UFRGS/HCPA-Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil., Roteli-Martins CM; Leonor M de Barros Hospital, São Paulo, Brazil., de Carvalho NS; Department of Gynecology and Obstetrics, Gynecology and Obstetrics Infectious Diseases Sector, University of Parana, Curitiba, Parana, Brazil., de Borba PC; Instituto de Prevenção do Câncer, Fortaleza, Brazil., Teixeira JC; Department of Gynecology, Oncology Division, State University of Campinas, Campinas, Brazil., Blatter M; Pediatric Alliance, Pittsburgh, Pennsylvania, USA., Moscicki AB; Department of Pediatrics, University of California, San Francisco, California, USA., Harper DM; Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA., Romanowski B; University of Alberta, Edmonton, Alberta, Canada., Tyring SK; Departments of Microbiology/Molecular Genetics, Dermatology & Internal Medicine, The University of Texas Medical School, Houston, Texas, USA., Ramjattan B; First Line Medical Services Ltd., St. John's, Newfoundland and Labrador, Canada., Schuind A; GSK Vaccines, King of Prussia, Pennsylvania, USA., Dubin G; GSK Vaccines, King of Prussia, Pennsylvania, USA., Franco EL; Division of Cancer Epidemiology, McGill University, Montreal, Quebec, Canada.

Publikováno v: BMJ open [BMJ Open] 2016 Aug 26; Vol. 6 (8), pp. e011371. Date of Electronic Publication: 2016 Aug 26.

Impact of catch-up human papillomavirus vaccination on cervical conization rate in a real-life population in France.

Autor: Eliès, Antoine¹ (AUTHOR) antoineelies@free.fr, Bonneau, Claire^1,2 (AUTHOR), Houzard, Sophie¹ (AUTHOR), Rouzier, Roman^1,2 (AUTHOR), Héquet, Delphine^1,2 (AUTHOR)

Publikováno v: PLoS ONE. 3/11/2022, Vol. 17 Issue 3, p1-12. 12p.

Long‐term persistence of immune response to the AS04‐adjuvanted HPV‐16/18 vaccine in Chinese girls aged 9‐17 years: Results from an 8‐9‐year follow‐up phase III open‐label study.

Autor: Hu, Yuemei¹ (AUTHOR) huyuemei@hotmail.com, Zhang, Xiang² (AUTHOR), He, Yilin² (AUTHOR), Ma, Zhilong² (AUTHOR), Xie, Yan² (AUTHOR), Lu, Xiangbin² (AUTHOR), Xu, Yabin² (AUTHOR), Zhang, Yanqiu² (AUTHOR), Jiang, Yunyu² (AUTHOR), Xiao, Hui² (AUTHOR), Struyf, Frank³ (AUTHOR), Folschweiller, Nicolas³ (AUTHOR), Jiang, Johny⁴ (AUTHOR), Poncelet, Sylviane³ (AUTHOR), Karkada, Naveen³ (AUTHOR), Jastorff, Archana⁵ (AUTHOR), Borys, Dorota³ (AUTHOR)

Publikováno v: Asia Pacific Journal of Clinical Oncology. Dec2020, Vol. 16 Issue 6, p392-399. 8p.

Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18-25 years: event-triggered analysis of a randomized controlled trial.

Autor: Zhu, Feng‐cai¹, Hu, Shang‐Ying², Hong, Ying³, Hu, Yue‐Mei¹, Zhang, Xun², Zhang, Yi‐Ju¹, Pan, Qin‐Jing², Zhang, Wen‐Hua², Zhao, Fang‐Hui² zhaofangh@cicams.ac.cn, Zhang, Cheng‐Fu⁴, Yang, Xiaoping⁵, Yu, Jia‐Xi⁶, Zhu, Jiahong⁴, Zhu, Yejiang⁷, Chen, Feng², Zhang, Qian², Wang, Hong², Wang, Changrong⁵, Bi, Jun⁶, Xue, Shiyin⁴

Publikováno v: Cancer Medicine. Jan2017, Vol. 6 Issue 1, p12-25. 14p.